Gene · 7409
Papers3,486
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,486
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exosomal miRNAs in hepatitis B virus related liver disease: a new hope for biomarker. | Gut Pathog | 2020 | 32346400 | PubTator, text mining | PubMed |
| Anti-Inflammatory Functions of Alverine via Targeting Src in the NF-κB Pathway. | Biomolecules | 2020 | 32326535 | PubTator, text mining | PubMed |
| P66Shc: A Pleiotropic Regulator of B Cell Trafficking and a Gatekeeper in Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2020 | 32325830 | PubTator, text mining | PubMed |
| ERK Activation in CAR T Cells Is Amplified by CD28-Mediated Increase in CD3ζ Phosphorylation. | iScience | 2020 | 32325413 | PubTator, text mining | PubMed |
| Targeting Rac and Cdc42 GEFs in Metastatic Cancer. | Front Cell Dev Biol | 2020 | 32322580 | PubTator, text mining | PubMed |
| Ehrlichia chaffeensis Uses an Invasin To Suppress Reactive Oxygen Species Generation by Macrophages via CD147-Dependent Inhibition of Vav1 To Block Rac1 Activation. | mBio | 2020 | 32317318 | PubTator, text mining | PubMed |
| Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs. | Nat Immunol | 2020 | 32313245 | PubTator, text mining | PubMed |
| Pharmacological targeting of natural killer cells for cancer immunotherapy. | Cancer Sci | 2020 | 32301190 | PubTator, text mining | PubMed |
| Differential IL-18 Dependence of Canonical and Adaptive NK Cells for Antibody Dependent Responses to P. falciparum. | Front Immunol | 2020 | 32296438 | PubTator, text mining | PubMed |
| Checking NEKs: Overcoming a Bottleneck in Human Diseases. | Molecules | 2020 | 32294979 | PubTator, text mining | PubMed |
| QuaDMutNetEx: a method for detecting cancer driver genes with low mutation frequency. | BMC Bioinformatics | 2020 | 32293263 | PubTator, text mining | PubMed |
| Natural Killer Cells: Tumor Surveillance and Signaling. | Cancers (Basel) | 2020 | 32290478 | PubTator, text mining | PubMed |
| Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas. | Nat Commun | 2020 | 32286303 | PubTator, text mining | PubMed |
| Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches. | Cancers (Basel) | 2020 | 32283827 | PubTator, text mining | PubMed |
| Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice. | Life Sci Alliance | 2020 | 32277014 | PubTator, text mining | PubMed |
| Nrf1 Is Endowed with a Dominant Tumor-Repressing Effect onto the Wnt/β-Catenin-Dependent and Wnt/β-Catenin-Independent Signaling Networks in the Human Liver Cancer. | Oxid Med Cell Longev | 2020 | 32273945 | PubTator, text mining | PubMed |
| Immunomodulation of the Natural Killer Cell Phenotype and Response during HCV Infection. | J Clin Med | 2020 | 32268490 | PubTator, text mining | PubMed |
| NGS Evaluation of Colorectal Cancer Reveals Interferon Gamma Dependent Expression of Immune Checkpoint Genes and Identification of Novel IFNγ Induced Genes. | Front Immunol | 2020 | 32265897 | PubTator, text mining | PubMed |
| Roscovitine enhances all-trans retinoic acid (ATRA)-induced nuclear enrichment of an ensemble of activated signaling molecules and augments ATRA-induced myeloid cell differentiation. | Oncotarget | 2020 | 32256976 | PubTator, text mining | PubMed |
| Exploring immune-related genes with prognostic value in microenvironment of breast cancer from TCGA database. | Medicine (Baltimore) | 2020 | 32243373 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7409/papers?page=53